| Financial Year |
March 31 2023 |
| Monetary Funds |
23,393,045.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
259,198,606.04 |
| Advances to Suppliers |
101,574,902.53 |
| Other Receivables |
9,191,891.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,877,145.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
697,848.00 |
| Other Current Assets |
6,308,379.41 |
| Total Current Assets |
483,592,162.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,217,012.97 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,740,698.63 |
| R&D expenses |
1,315,800.00 |
| Goodwill |
83,440,096.32 |
| Long-Term Deferred and Prepaid Expenses |
14,513,789.69 |
| Deferred Income Tax Assets |
33,721,919.64 |
| Other Non-Current Assets |
1,164,984.43 |
| Sub-Total of Non-Current Assets |
179,034,248.70 |
| Total Assets |
662,626,411.14 |
| Short-Term Loans |
28,025,934.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
49,349,889.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,143,246.28 |
| Taxes Payable |
7,123,386.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
32,220,779.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,663,820.78 |
| Other Current Liabilities |
2,643,795.64 |
| Sub-Total of Current Liabilities |
166,156,837.35 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
187,509.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,434,896.62 |
| Total Liabilities |
173,591,733.97 |
| Paid-In Capital(Or Share Stock) |
641,706,416.00 |
| Capital Surplus |
473,344,939.60 |
| Surplus Reserve |
25,714,342.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-654,964,637.91 |
| Minority Stockholder's Interest |
474,342.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
488,560,335.07 |
| Owner's Equity（Stockholder's Equity） |
489,034,677.17 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
662,626,411.14 |
